Proteomics-Based Biomarkers

Proteomics-based biomarkers

Mass spectrometry (MS) is a powerful tool for biomarker discovery and validation, offering unparalleled specificity and sensitivity in clinical research. At OHMX.bio, we provide state-of-the-art mass spec-based biomarker services to support both exploratory and targeted biomarker applications.

Mass spectrometry in clinical research

Mass spectrometry is widely used in clinical research for both biomarker discovery and precise quantification. As a discovery tool, it enables the identification of novel biomarkers from complex biological samples. As a measurement tool, it ensures accurate and reproducible quantification of known biomarkers, supporting clinical decision-making and regulatory requirements.

MRM measurements & targeted assays

One of the most reliable applications of mass spectrometry in biomarker validation is through Multiple Reaction Monitoring (MRM). MRM enables precise and reproducible quantification of target biomarkers in complex biological matrices, making it an essential tool for clinical research and diagnostics. Our MRM-based assays are optimized for sensitivity, ensuring robust measurement of low-abundance biomarkers.
OHMX.bio is equipped with state-of-the-art instruments perfectly fit for clinical research.
OHMX.bio - Innovative omics solutions

Let’s get in touch!

Are you curious about how we can work on your -omics challenges together? Fill out the form below!
Our experts will reply within 2 working days to freely discuss your omics project.

Our publications using mass-spec based biomarker services

  1.